Nouvelles stratégies thérapeutiques dans le lupus érythémateux systémique d’après le congrès de l’EULAR 2023
-
Published:2024-07
Issue:4
Volume:91
Page:454-461
-
ISSN:1169-8330
-
Container-title:Revue du Rhumatisme
-
language:fr
-
Short-container-title:Revue du Rhumatisme
Author:
Carvajal Alegria GuillermoORCID,
Felten Renaud
Reference31 articles.
1. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update;Fanouriakis;Ann Rheum Dis,2024
2. EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis;Parodis;Ann Rheum Dis,2023
3. Two-year, randomized, controlled trial of belimumab in lupus nephritis;Furie;N Engl J Med,2020
4. Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial;Rovin;Lancet,2021
5. Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial;Jourde-Chiche;Ann Rheum Dis,2022